1. Karinharju KS, Boughey AM, Tweedy SM, Clanchy KM, Trost SG, Gomersall SR. Validity of the Apple Watch® for monitoring push counts in people using manual wheelchairs. J Spinal Cord Med 2019;1-9.
[CROSSREF]
2. Hernando D, Roca S, Sancho J, Alesanco A, Bailon R. Validation of the Apple watch for heart rate variability measurements during relax and mental stress in healthy subjects. Sensors (Basel) 2018;18:2619.
[CROSSREF] [PMC]
3. Raja JM, Elsakr C, Roman S, Cave B, Pour-Ghaz I, Nanda A, et al. Apple watch, wearables, and heart rhythm: where do we stand? Ann Transl Med 2019;7:417.
[CROSSREF] [PUBMED] [PMC]
4. Kim HS, Cho JH, Yoon KH. New directions in chronic disease management. Endocrinol Metab (Seoul) 2015;30:159-66.
[CROSSREF]
5. Kim HS, Kim H, Lee S, Lee KH, Kim JH. Current clinical status of telehealth in Korea: categories, scientific basis, and obstacles. Healthc Inform Res 2015;21:244-50.
[CROSSREF]
6. Lee J, Kim HS, KIM DJ. Recent technology-driven advancements in cardiovascular disease prevention. Cardiovasc Prev Pharmacother 2019;1:43-9.
[CROSSREF]
7. Nittas V, Lun P, Ehrler F, Puhan MA, Mutsch M. Electronic patient-generated health data to facilitate disease prevention and health promotion: scoping review. J Med Internet Res 2019;21:e13320.
[CROSSREF] [PUBMED] [PMC]
8. Kim HS, Kim DJ, Yoon KH. Medical big data is not yet available: why we need realism rather than exaggeration. Endocrinol Metab (Seoul) 2019;34:349-54.
[CROSSREF] [PUBMED] [PMC]
9. Mastrototaro J. The MiniMed continuous glucose monitoring system (CGMS). J Pediatr Endocrinol Metab 1999;12(Suppl 3):751-8.
[PUBMED]
10. Korean Diabetes Association. Treatment guideline for diabetes 2015. Seoul: Korean Diabetes Association; 2015.
11. Chetty VT, Almulla A, Odueyungbo A, Thabane L. The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in type I diabetic patients: a systematic review. Diabetes Res Clin Pract 2008;81:79-87.
[CROSSREF] [PUBMED]
12. Wei Q, Sun Z, Yang Y, Yu H, Ding H, Wang S. Effect of a CGMS and SMBG on maternal and neonatal outcomes in gestational diabetes mellitus: a randomized controlled trial. Sci Rep 2016;6:19920.
[CROSSREF] [PDF]
13. Kim HS, Shin JA, Chang JS, Cho JH, Son HY, Yoon KH. Continuous glucose monitoring: current clinical use. Diabetes Metab Res Rev 2012;28(Suppl 2):73-8.
[CROSSREF] [PUBMED]
14. Anderson SM, Dassau E, Raghinaru D, Lum J, Brown SA, Pinsker JE, et al. The international diabetes closed-loop study: testing artificial pancreas component interoperability. Diabetes Technol Ther 2019;21:73-80.
[CROSSREF] [PUBMED] [PMC]
15. Fernandez-Carames TM, Froiz-Miguez I, Blanco-Novoa O, Fraga-Lamas P. Enabling the internet of mobile crowdsourcing health things: a mobile fog computing, blockchain and IOT based continuous glucose monitoring system for diabetes mellitus research and care. Sensors (Basel) 2019;19:3319.
[CROSSREF] [PMC]
16. Jung SH, Kim JW, Kang IK, Park CY, Kim YS, Woo JT, et al. Continuous glucose monitoring is needed to detect unrecognized hypoglycemic event in diabetic patients with stroke. J Korean Diabetes 2002;3:140-51.
20. Kim HS, Choi W, Baek EK, Kim YA, Yang SJ, Choi IY, et al. Efficacy of the smartphone-based glucose management application stratified by user satisfaction. Diabetes Metab J 2014;38:204-10.
[CROSSREF] [PUBMED] [PMC]
21. Basu A, Dube S, Veettil S, Slama M, Kudva YC, Peyser T, et al. Time lag of glucose from intravascular to interstitial compartment in type 1 diabetes. J Diabetes Sci Technol 2015;9:63-8.
[CROSSREF] [PUBMED]
22. Bergenstal RM. Continuous glucose monitoring: transforming diabetes management step by step. Lancet 2018;391:1334-6.
[CROSSREF] [PUBMED]
23. Heinemann L. Continuous glucose monitoring (CGM) or blood glucose monitoring (BGM): interactions and implications. J Diabetes Sci Technol 2018;12:873-9.
[CROSSREF] [PUBMED] [PMC]
24. Knebel T, Neumiller JJ. Medtronic MiniMed 670G hybrid closed-loop system. Clin Diabetes 2019;37:94-5.
[CROSSREF] [PUBMED] [PMC]
25. Mazze RS. Acceptance of FGM or CGM in clinical decision-making and patient preference: where do we go from here? Diabetes Technol Ther 2017;19:142-4.
[CROSSREF] [PUBMED]
26. Kim HS, Lee KH, Kim H, Kim JH. Using mobile phones in healthcare management for the elderly. Maturitas 2014;79:381-8.
[CROSSREF] [PUBMED]
27. Kim HS, Hwang Y, Lee JH, Oh HY, Kim YJ, Kwon HY, et al. Future prospects of health management systems using cellular phones. Telemed J E Health 2014;20:544-51.
[CROSSREF] [PUBMED] [PMC]
28. Abraham SB, Arunachalam S, Zhong A, Agrawal P, Cohen O, McMahon CM. Improved real-world glycemic control with continuous glucose monitoring system predictive alerts. J Diabetes Sci Technol 2019 Jul 4 [Epub].
https://doi.org/10.1177/1932296819859334
.
[CROSSREF]
29. Kim HS. Decision-making in artificial intelligence: is it always correct? J Korean Med Sci 2020;35:e1.
[CROSSREF] [PUBMED]
30. Kim HS, Yang SJ, Jeong YJ, Kim YE, Hong SW, Cho JH. Satisfaction survey on information technology-based glucose monitoring system targeting diabetes mellitus in private local clinics in Korea. Diabetes Metab J 2017;41:213-22.
[CROSSREF] [PUBMED] [PMC]
31. Lim I, Walkup RK, Vannier MW. Rule based artificial intelligence expert system for determination of upper extremity impairment rating. Comput Methods Programs Biomed 1993;39:203-11.
[CROSSREF] [PUBMED]
32. Ratheau L, Jeandidier N, Moreau F, Sigrist S, Pinget M. How technology has changed diabetes management and what it has failed to achieve. Diabetes Metab 2011;37(Suppl 4):S57-64.
[CROSSREF] [PUBMED]
33. Reymann MP, Dorschky E, Groh BH, Martindale C, Blank P, Eskofier BM. Blood glucose level prediction based on support vector regression using mobile platforms. Conf Proc IEEE Eng Med Biol Soc 2016;2016:2990-3.
[CROSSREF]
34. Seo W, Lee YB, Lee S, Jin SM, Park SM. A machine-learning approach to predict postprandial hypoglycemia. BMC Med Inform Decis Mak 2019;19:210.
[CROSSREF] [PUBMED] [PMC] [PDF]
35. Weisman A, Bai JW, Cardinez M, Kramer CK, Perkins BA. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol 2017;5:501-12.
[CROSSREF] [PUBMED]
36. Boughton CK, Hovorka R. Is an artificial pancreas (closed-loop system) for type 1 diabetes effective? Diabet Med 2019;36:279-86.
[CROSSREF]
37. Yu S, Varughese B, Li Z, Kushner PR. Healthcare resource waste associated with patient nonadherence and early discontinuation of traditional continuous glucose monitoring in real-world settings: a multicountry analysis. Diabetes Technol Ther 2018;20:420-7.
[CROSSREF]
38. Kim HS, Sun C, Yang SJ, Sun L, Li F, Choi IY, et al. Randomized, open-label, parallel group study to evaluate the effect of internet-based glucose management system on subjects with diabetes in China. Telemed J E Health 2016;22:666-74.
[CROSSREF] [PUBMED]
39. Lin YR, Hung CC, Chiu HY, Chang BH, Li BR, Cheng SJ, et al. Noninvasive glucose monitoring with a contact lens and smartphone. Sensors (Basel) 2018;18:3208.
[CROSSREF] [PMC]
40. Ascaso FJ, Huerva V. Noninvasive continuous monitoring of tear glucose using glucose-sensing contact lenses. Optom Vis Sci 2016;93:426-34.
[CROSSREF]
41. Zhang J, Hodge W, Hutnick C, Wang X. Noninvasive diagnostic devices for diabetes through measuring tear glucose. J Diabetes Sci Technol 2011;5:166-72.
[CROSSREF] [PUBMED] [PMC]
42. O’Donnell C, Efron N. Diabetes and contact lens wear. Clin Exp Optom 2012;95:328-37.
[CROSSREF] [PUBMED]
43. Lee H, Song C, Hong YS, Kim MS, Cho HR, Kang T, et al. Wearable/disposable sweat-based glucose monitoring device with multistage transdermal drug delivery module. Sci Adv 2017;3:e1601314.
[CROSSREF] [PUBMED] [PMC]
44. Tankasala D, Linnes JC. Noninvasive glucose detection in exhaled breath condensate. Transl Res 2019;213:1-22.
[CROSSREF] [PUBMED]
45. Bandodkar AJ, Jia W, Yardimci C, Wang X, Ramirez J, Wang J. Tattoo-based noninvasive glucose monitoring: a proof-of-concept study. Anal Chem 2015;87:394-8.
[CROSSREF] [PUBMED]
46. Rossen J, Yngve A, Hagstromer M, Brismar K, Ainsworth BE, Iskull C, et al. Physical activity promotion in the primary care setting in pre- and type 2 diabetes: the Sophia step study, an RCT. BMC Public Health 2015;15:647.
[CROSSREF] [PUBMED] [PMC] [PDF]
47. Groat D, Kwon HJ, Grando MA, Cook CB, Thompson B. Comparing real-time self-tracking and device-recorded exercise data in subjects with type 1 diabetes. Appl Clin Inform 2018;9:919-26.
[CROSSREF] [PUBMED] [PMC] [PDF]